Testing method helps predict progression to cerebral malaria

05/10/2013 | InfectionControlToday.com

Testing the blood for the protein HRP2 may be an effective way to determine whether pediatric patients with malaria are likely to develop the cerebral form of the disease, according to a study in the Journal of Infectious Diseases. The method was accurate at predicting the course of cases at a hospital in Malawi. Researchers are working on a more cost-effective version of the testing method.

View Full Article in:

InfectionControlToday.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA